full free access EDITORIAL: Designing Early Detection Programs for Ovarian Cancer -- JNCI

"...Despite the discovery that CA125 and other serum markers increase before the clinical onset of ovarian cancer, it has proven surprisingly difficult to devise a successful screening program for asymptomatic women with ovarian cancer.....For now, we do not have a proven biomarker, panel of biomarkers, or overall screening program that works well. The current report, with its sobering implications, brings us closer to understanding the crucial elements in designing any effective early detection program for ovarian cancer...."